'We feel very confident that we had a very good piece of legislation,' Ginette Petitpas Taylor says.

Prime Minister Justin Trudeau's bill legalizing recreational pot may have passed third reading in the Senate — but that doesn't mean its legislative journey will be a smooth or easy one from now on.

Senators made dozens of amendments to the government bill they sent back to the Commons Thursday night. Some of those amendments are likely to end up in the final bill. Others may not.

"We will have to go through the amendments. The minister will really provide information as to what amendments we are able to support, what amendments we're not able to support," said Liberal House Leader Bardish Chagger.

The Sault is one of 14 locations chosen for the new Ontario Cannabis Store.

City council in Sault Ste. Marie could give the cold shoulder Monday night to a legal pot shop planned for the city.

The Sault is one of 14 cities the Ontario Cannabis Store is looking to do business in later this summer, after the federal government legalizes marijuana.

City councillor Susan Myers has tabled a motion calling on Sault city council to oppose the province's plans.

She's worried legal recreational marijuana will only make the city's opiate problems—which got national news attention earlier this year— worse.

"It's a feeder to more serious drugs," says Myers.  

The analysts expect 'meaningful legal recreational sales' to roll-out on a national level by September/October.

Analysts at Canaccord Genuity hailed the Canadian Senate’s decision Thursday to legalize recreational marijuana as a “watershed moment” and they expect cannabis to go on sale by September or October.

However, the analysts pointed out that there were several logistical hurdles because new retail systems needed time to launch successfully.

Anybody who’s hoping to get a piece of the cannabis market pie is watching closely as the Canadian government establishes the regulatory framework for production, distribution, and sales.

The North American Marijuana Index fell on Thursday, as pot stock investors celebrated the Canadian Senate’s passage of Bill C-45, which is set to legalize marijuana following 95 years of prohibition across the country. Following a vote of 56 to 30, with one abstention, in favor of the legislation, the bill heads back to to the House of Commons where MPs will have to vote on nearly four dozen amendments added by the Senate. Although mostly minor, some amendments do place considerable restrictions on Canadians, such as one allowing provinces to ban home cultivation of cannabis.

As Canada gets closer to the legalization of recreational cannabis, many experts have debated the supply and demand relationship for the legal product the market will produce.

Observers of the industry have noted that licensed producers (LPs) have failed to disclose information on a material level as far as size of inventories in grams produced.

“Unfortunately, not all of the LPs are reporting the size of their inventories in grams, with the three largest LPs in terms of the dollar amount of inventory silent on the issue,” Alan Brochstein, cannabis analyst with 420 Investor, wrote in a column addressing the shortage.

Cannabis company assesses compliance from labels to licensing.

Cannabis commerce is evolving dynamically and often dramatically. To stay abreast of up-to-the-minute regulations and current competitive landscape, cannabis-related companies need a highly skilled compliance partner.

Denver’s Highmark Data was founded to address all key business and legal intelligence needed to make the smartest and most compliant decisions. Cannabis companies partnering with Highmark Data can continue revving up their growth engine while ensuring full adherence to the latest municipal, state and federal regulations and “murmurings” that may substantially impact business operations.

Despite rapidly expanding its weed-growing capacity, this marijuana stock is at risk of being late to the party.

The legal marijuana industry is literally budding before our eyes. According to cannabis research firm ArcView, legal weed sales in North America surged higher by 33% in 2017 to $9.7 billion, and they're estimated to grow by an average of 28% through 2021 to nearly $25 billion. It's this rapid growth that's been pivotal in attracting investors to pot stocks, as well as driving up their valuations.

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) comments on today's Canadian Senate's vote in favour of Bill C-45, which governs the legalization of the adult consumer use of cannabis.

A Canadian fish oil supplement supplier, a business that hopes to enter the medical marijuana industry, is warning of the risks posed by the “rapidly-evolving” cannabis industry and uncertainty over Health Canada’s license approval process.

Health, safety and environmental regulations “are subject to change and development,” Neptune Technologies & Bioressources Inc. said in its management discussion and analysis of its financial results, released Tuesday. Quebec-based Neptune, a vendor of fish oil, is applying for a licence with Health Canada to produce cannabis oil.